Drug Profile
Research programme: humanised anti glycoprotein Ib murine monoclonal antibodies - Oxurion
Alternative Names: Fab 6B4; Humanised anti glycoprotein Ib murine monoclonal antibodies research programme - Oxurion; Humanised murine anti-GP Ib-Mab 6B4 - Oxurion; TGX 6B4Latest Information Update: 11 Sep 2018
Price :
$50
*
At a glance
- Originator University of Leuven
- Class Monoclonal antibodies
- Mechanism of Action GPIb receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Arterial thrombosis
Most Recent Events
- 10 Sep 2018 Thrombogenics is now called Oxurion
- 04 Nov 2017 No recent reports of development identified for preclinical development in Arterial-thrombosis in Europe (Parenteral, Injection)
- 04 Jan 2007 Preclinical development is ongoing